Login to Your Account



U.S. lawmakers seek HELP for nebulous 340B Drug Discount program

By Mari Serebrov
Regulatory Editor

Wednesday, May 16, 2018

The finger pointing over U.S. drug prices continued Tuesday as members of the Senate Health, Education, Labor and Pensions (HELP) Committee once again tried to grope their way through the nebulous fog of the 340B Discount Drug program.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription